Komori
Ferrotec (6890) · TargetRestated

Expanding Sales of Medical and Dental Testing Equipment and Related Products

First written in FY2016. 6 of 11 entries say "Restated". Latest entry: FY2026.

11entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2022-Q3WorsenedFY20242016: 120162017: 020172018: 120182019: 020192020: 220202021: 020212022: 220222023: 220232024: 220242025: 020252026: 12026
Same theme, other companies

Ferrotec moved to the "Worse" side of this theme in 2023.

1 other company's latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「In the biotechnology and medical fields, we will expand sales of blood analyzers, DNA amplification systems and regenerative medicine equipment that use our thermoelectric-device thermoelectric modules. We will continue to supply ceramic products used in telemedicine equipment.」

    The company continues to pursue its strategy of expanding thermoelectric module and ceramic product applications in the medical and biomedical fields.
  2. FY2024WorsenedAnnual report

    「Thermoelectric module sales to PCR testing equipment declined sharply, but the decrease was offset by higher sales to the communications sector, particularly high-capacity optical transceivers attracting attention in connection with generative AI, resulting in overall revenue growth.」

    Shipments to medical applications and PCR testing equipment declined over the full fiscal year. Meanwhile, the communications sector offset the decline, with trends varying by application.
  3. FY2024-Q3RestatedAnnual report

    「Sales declined for thermoelectric modules, mainly because shipments for medical applications, particularly PCR testing systems, decreased.」

    Shipments to medical applications, particularly PCR testing equipment, continued to decline, reaffirming the weakening of the company's medical and biomedical business.
  4. FY2024-Q2WorsenedAnnual report

    「Sales declined mainly because shipments of our core thermoelectric modules to medical applications, particularly PCR testing equipment, decreased.」

    In the medical and biomedical fields, shipments to medical applications, particularly PCR testing equipment, declined, leading to lower thermoelectric module sales.
  5. FY2023Some weakness in medical applications and overall sales growthAnnual report

    「Our core thermoelectric modules maintained high sales levels, mainly to mobile communications system equipment for 5G. Although sales to PCR testing equipment in the medical sector stagnated in the second half, overall sales increased substantially.」

    Although sales of PCR testing equipment for medical applications stagnated in the second half of the fiscal year, thermoelectric module sales increased substantially overall, with performance in the medical and biotechnology fields varying by application.
  6. FY2023-Q1AdvancedAnnual report

    「Sales of our core thermoelectric modules to automotive climate-controlled seats weakened, but sales to mobile communications system equipment for 5G, the semiconductor sector and the medical sector increased.」

    The company stated that sales of thermoelectric modules for the medical sector increased, indicating progress in expansion into medical testing equipment and other applications.
  7. FY2022-Q3RestatedAnnual report

    「Our core thermoelectric modules have maintained stable sales to mobile communications system equipment for 5G and medical testing equipment, including PCR equipment,」

    The company explained that sales to 5G mobile communications system equipment and medical testing equipment, including PCR equipment, have continued steadily.
  8. FY2021-Q2RestatedAnnual report

    「Business for equipment for next-generation 5G mobile communications systems and medical testing equipment, including PCR systems, performed as planned.」

    The company explained that expansion into 5G communications equipment and medical testing equipment, including PCR equipment, is progressing as planned.
  9. FY2020RestatedAnnual report

    「In the biotechnology and medical fields, we will expand sales of DNA amplification systems, including PCR testing equipment, blood analyzers and regenerative medicine equipment that use our thermoelectric-device thermoelectric modules. We will continue to supply ceramic products used in telemedicine equipment.」

    The company reaffirmed its strategy of expanding sales to PCR testing equipment, blood analyzers, regenerative medicine equipment and telemedicine equipment.
  10. FY2018RestatedAnnual report

    「③ In the biomedical field, we will expand sales into DNA amplification systems and blood analysers using thermoelectric elements, regenerative-medicine equipment and other products.」

    In the medical and biomedical fields, the company has defined a strategy to expand sales of DNA amplification systems, blood analyzers and regenerative medicine equipment.
  11. FY2016First statedAnnual report

    「② Expansion of sales of medical and dental testing equipment and related equipment」

    The company explicitly stated that expanding sales is part of its short-term business strategy.
Moved together

"Securing stable earnings power and improving the financial position" moved the same way as this thread, in the same document, in 3 of its 11 moves.

3222★1234
  1. ★This thread
  2. 1Securing stable earnings power and improving the financial position3×
  3. 2Recovery in business performance and improvement in operating profit2×
  4. 3Balancing Retained Earnings with Stable Returns to Shareholders2×
  5. 4Risk of declines in the market value of securities holdings2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Ferrotec yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.